U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1413_1414delinsGGACAT (p.Gln474fs) AND Cardiovascular phenotype

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003352899.2

Allele description [Variation Report for NM_000527.5(LDLR):c.1413_1414delinsGGACAT (p.Gln474fs)]

NM_000527.5(LDLR):c.1413_1414delinsGGACAT (p.Gln474fs)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1413_1414delinsGGACAT (p.Gln474fs)
HGVS:
  • NC_000019.10:g.11113589_11113590delinsGGACAT
  • NG_009060.1:g.29209_29210delinsGGACAT
  • NM_000527.4:c.1413_1414delAGinsGGACAT
  • NM_000527.5:c.1413_1414delinsGGACATMANE SELECT
  • NM_001195798.2:c.1413_1414delinsGGACAT
  • NM_001195799.2:c.1290_1291delinsGGACAT
  • NM_001195800.2:c.909_910delinsGGACAT
  • NM_001195803.2:c.1032_1033delinsGGACAT
  • NP_000518.1:p.Gln474fs
  • NP_001182727.1:p.Gln474fs
  • NP_001182728.1:p.Gln433fs
  • NP_001182729.1:p.Gln306fs
  • NP_001182732.1:p.Gln347fs
  • LRG_274t1:c.1413_1414delAGinsGGACAT
  • LRG_274:g.29209_29210delinsGGACAT
  • NC_000019.9:g.11224265_11224266delinsGGACAT
Protein change:
Q306fs
Links:
dbSNP: rs1555805360
NCBI 1000 Genomes Browser:
rs1555805360
Molecular consequence:
  • NM_000527.5:c.1413_1414delinsGGACAT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195798.2:c.1413_1414delinsGGACAT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195799.2:c.1290_1291delinsGGACAT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195800.2:c.909_910delinsGGACAT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195803.2:c.1032_1033delinsGGACAT - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004053896Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Aug 23, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.

Pirillo A, Garlaschelli K, Arca M, Averna M, Bertolini S, Calandra S, Tarugi P, Catapano AL; LIPIGEN Group..

Atheroscler Suppl. 2017 Oct;29:17-24. doi: 10.1016/j.atherosclerosissup.2017.07.002.

PubMed [citation]
PMID:
28965616

Details of each submission

From Ambry Genetics, SCV004053896.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The c.1413_1414delAGinsGGACAT pathogenic mutation, located in coding exon 10 of the LDLR gene, results from the deletion of two nucleotides and insertion of 6 nucleotides causing a translational frameshift with a predicted alternate stop codon (p.Q474Hfs*63). This variant has been previously reported in a familial hypercholesterolemia (FH) cohort (Pirillo A et al. Atheroscler Suppl, 2017 Oct;29:17-24). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024